Data as of Jan 29
| +0.08 / +1.74%|
RTI Surgical, Inc. provides sterile biological implants for surgeries around the world. The company recovers and processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine animal tissue in producing allograft and xenograft implants utilizing proprietary BIOCLEANSE and TUTOPLAST sterilization processes, for distribution to hospitals and surgeons. It produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes. The company's business lines are comprised of five categories: Sports Medicine, Spine, Surgical Specialties, Bone Graft Substitutes & General Orthopedic, and Dental. The Sports Medicine business category's implants and products include BioCleanse Meniscus, Bone-Tendon-Bone Select, BioCleanse Peroneus Longus, Sterling Xenograft Wedge, osteochondral and Matrix HD. Its allografts are tendons for ligament reconstruction and meniscal allografts are for transplantation. The Spine business includes precision machined implants and bone paste utilized in spinal procedures. The Surgical Specialties business distributes implants for hernia, breast reconstruction, urology, ophthalmology, and ENT. The orthopedic business includes General Orthopedic and Trauma Allografts and Bone Graft Substitutes. The Dental business provides various implants including cancellous and cortical bone and human and bovine membranes primarily for dental procedures related to augmenting ridge restoration. The company was founded on February 27, 2008 and is headquartered in Alachua, FL.
|Brian K. Hutchison||President, Chief Executive Officer & Director|
|Robert P. Jordheim||CFO, Executive VP & Head-Investor Relations|
|Caroline A. Hartill||Chief Scientific Officer & Executive VP|
|Lennox K. Archibald||Medical Director|
|Michael J. Laprade||Vice President & General Manager|